Articoli con mandati relativi all'accesso pubblico - Matt van de RijnUlteriori informazioni
Non disponibili pubblicamente: 3
Exploratory process development of pexidartinib through the tandem Tsuji–Trost reaction and Heck coupling
D Chen, Y Zhang, J Li, Y Liu
Synthesis 51 (12), 2564-2571, 2019
Mandati: National Natural Science Foundation of China
Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis
NQ Bui, N Nemat-Gorgani, A Subramanian, IA Torres, M Lohman, ...
Clinical Cancer Research 29 (14), 2612-2620, 2023
Mandati: US National Institutes of Health
CRISPR-SID
T Naert, D Tulkens, T Van Nieuwenhuysen, J Przybyl, S Demuynck, ...
Proceedings of the National Academy of Sciences of the United States of …, 2021
Mandati: Research Foundation (Flanders)
Disponibili pubblicamente: 92
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
SB Willingham, JP Volkmer, AJ Gentles, D Sahoo, P Dalerba, SS Mitra, ...
Proceedings of the National Academy of Sciences 109 (17), 6662-6667, 2012
Mandati: US National Institutes of Health
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
Mandati: US National Institutes of Health
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
AD Boiko, OV Razorenova, M Van De Rijn, SM Swetter, DL Johnson, ...
Nature 466 (7302), 133-137, 2010
Mandati: US National Institutes of Health
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
KS Chan, I Espinosa, M Chao, D Wong, L Ailles, M Diehn, H Gill, ...
Proceedings of the National Academy of Sciences 106 (33), 14016-14021, 2009
Mandati: US National Institutes of Health
CDX2 as a prognostic biomarker in stage II and stage III colon cancer
P Dalerba, D Sahoo, S Paik, X Guo, G Yothers, N Song, N Wilcox-Fogel, ...
New England Journal of Medicine 374 (3), 211-222, 2016
Mandati: US National Institutes of Health
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies
K Weiskopf, AM Ring, CCM Ho, JP Volkmer, AM Levin, AK Volkmer, ...
Science 341 (6141), 88-91, 2013
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, German …
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
K Weiskopf, NS Jahchan, PJ Schnorr, S Cristea, AM Ring, RL Maute, ...
The Journal of clinical investigation 126 (7), 2610-2620, 2016
Mandati: US Department of Energy, US National Institutes of Health, Howard Hughes …
Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract
PJ Gomez-Pinilla, SJ Gibbons, MR Bardsley, A Lorincz, MJ Pozo, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 296 (6 …, 2009
Mandati: US National Institutes of Health
Three differentiation states risk-stratify bladder cancer into distinct subtypes
JP Volkmer, D Sahoo, RK Chin, PL Ho, C Tang, AV Kurtova, ...
Proceedings of the National Academy of Sciences 109 (6), 2078-2083, 2012
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, German …
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
B Clarke, AV Tinker, CH Lee, S Subramanian, M Van De Rijn, D Turbin, ...
Modern Pathology 22 (3), 393-402, 2009
Mandati: US National Institutes of Health
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
B Edris, K Weiskopf, AK Volkmer, JP Volkmer, SB Willingham, ...
Proceedings of the National Academy of Sciences 109 (17), 6656-6661, 2012
Mandati: US National Institutes of Health
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers
AL Brunner, AH Beck, B Edris, RT Sweeney, SX Zhu, R Li, K Montgomery, ...
Genome biology 13, 1-13, 2012
Mandati: US National Institutes of Health, Howard Hughes Medical Institute
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma
CH Lee, WB Ou, A Mariño-Enriquez, M Zhu, M Mayeda, Y Wang, X Guo, ...
Proceedings of the National Academy of Sciences 109 (3), 929-934, 2012
Mandati: US National Institutes of Health
The macrophage colony-stimulating factor 1 response signature in breast carcinoma
AH Beck, I Espinosa, B Edris, R Li, K Montgomery, S Zhu, S Varma, ...
Clinical Cancer Research 15 (3), 778-787, 2009
Mandati: US National Institutes of Health
Mapping a multiplexed zoo of mRNA expression
HMT Choi, CR Calvert, N Husain, D Huss, JC Barsi, BE Deverman, ...
Development 143 (19), 3632-3637, 2016
Mandati: US National Science Foundation, US National Institutes of Health, UK Medical …
A compact VEGF signature associated with distant metastases and poor outcomes
Z Hu, C Fan, C Livasy, X He, DS Oh, MG Ewend, LA Carey, ...
BMC medicine 7, 1-14, 2009
Mandati: US National Institutes of Health
Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival
AHG Cleven, GA Al Sannaa, I Briaire-de Bruijn, DR Ingram, ...
Modern pathology 29 (6), 582-590, 2016
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software